Albertsons Companies Inc. (ACI)
Description
One of the largest food and drug retailers in the United States, operating 2,270 stores across 34 states under banners such as Albertsons, Safeway, Vons, and others, with integrated pharmacies, fuel centers and digital platforms.
Historical Reports
Financial Information
- Report Date
- 2024-11-30
- Report Period
- Quarter ended November 2024
- Debt
- $78,384 million
- Debt History
- Shrinking by approximately 2.9% year‑over‑year
- Debt Trend
- Decreasing
Profit Information
- Profit
- $4,006 million
- Profit History
- Growing by approximately 10.9% year‑over‑year
- Profit Trend
- Increasing
Detailed Report
Albertsons Companies, Inc. Q3 2024 Financial Analysis
Report Date: 2024‑11‑30
Period Covered: Quarter ended November 2024
Form Type: 10‑Q
Executive Summary
Albertsons delivered net income of $4.006 billion in Q3 2024, up 10.9% from $3.614 billion in Q3 2023, on revenues of $187.7 billion (up 1.1%). Total debt declined 2.9% year‑over‑year to $78.38 billion, reflecting disciplined leverage management.
Profit and Loss Analysis
- Net Sales rose to $187.7 B (+1.1%), driven by a 1.2% increase in same‑store sales excluding fuel, strong pharmacy growth and expanding digital channels (home delivery, curbside pickup). Fuel sales declined slightly.
- Gross Margin Rate was 27.9% vs. 28.0% in Q3 2023. Excluding fuel and LIFO impacts, margin fell ~50 bps due to higher fulfillment costs for digital and mix shift toward lower‑margin pharmacy. Productivity and vendor funding partly offset these costs.
- SG&A as a % of sales increased to 25.1% from 24.8%, reflecting merger‑related costs, higher occupancy and security expenses, partially offset by labor productivity initiatives.
- Impairments and asset dispositions were $102 million vs. $239 million in Q3 2023, driven by store and technology write‑downs.
- Interest expense decreased from $1.163 B to $1.090 B, reflecting lower average borrowings.
- Effective Tax Rate fell to 3.6% from 26.8%, driven by a $810 million discrete state tax benefit.
Balance Sheet & Cash Flow
- Total Debt: $78.38 B (down 2.9% YoY)
- Cash & Equivalents: $2.065 B at quarter end
- Operating Cash Flow: $19.22 B (vs. $17.31 B prior year)
- Capital Expenditures: $14.47 B for store remodels, new stores and digital platforms
- Financing: $2.50 B repayment on credit facilities; $0.5 B new borrowings; $2.085 B dividends paid
Key Drivers
- Pharmacy: Record quarterly pharmacy revenue, now >$5 B in receivables, contributed to top‑line growth.
- Digital: Double‑digit digital sales growth fueled by expanded fulfillment capacity and loyalty integration.
- Cost Control: Productivity programs and vendor allowances offset inflationary pressures in labor and freight.
- Capital Allocation: Continued investment in technology, omni‑channel capabilities and selected real estate disposals to streamline portfolio.
Pros & Cons
Pros:
- Resilient same‑store sales growth excluding fuel
- Strong cash flow generation supports debt pay‑down and dividends
- Expanding omni‑channel reach and loyalty program
- Tax benefits significantly lower effective tax rate
Cons:
- Compression in gross margin from digital fulfillment costs
- Elevated SG&A from merger‑related and occupancy expenses
- Exposure to legal and regulatory proceedings (opioid, FCA suits)
- Debt remains elevated at ~$78 B
Outlook
Albertsons enters Q4 2024 with a solid liquidity position (cash + $39.6 B available credit) and a clear standalone strategy following the terminated Kroger merger. Continued investments in technology and loyalty, alongside margin recovery and debt reduction, should underpin earnings growth even amid macro‑volatile consumer spending.
Statistics Breakdown
- Revenue by product category (Q3 2024):
• Grocery & Frozen Foods ~50%
• Produce, Meat & Deli ~32%
• General Merchandise & DME ~10%
• Pharmacy sales recorded $5.453 B receivables
• Fuel and other services ~8% - Digital sales mix: Home delivery & curbside pickup up over 20% YoY
- Same‑store sales excluding fuel: +1.2% YoY
- Pharmacy accounts receivable: $5.453 B vs. $3.761 B prior year
- Gift card liability: $1.193 B unredeemed balance at quarter end
Company Direction Insights
Albertsons is on a positive growth trajectory supported by consistent same‑store sales expansion (ex‑fuel), robust digital channel adoption and high‑margin pharmacy growth. Key financial health indicators—namely improving cash flow, declining leverage and lower interest costs—provide a buffer against economic headwinds. Future challenges include margin pressure from omnichannel fulfillment costs, SG&A inflation and legal contingencies (opioid, FCA litigation). Opportunities lie in further automation, loyalty monetization and selective real estate optimization to drive margin expansion and debt reduction.